Immunisation status of children under 2 years of age visiting Khyber Teaching Hospital, Peshawar, Pakistan: a

Jehan Hussan1, Laiba Gul2, Mehran Ali3

  • 1Community Medicine, Khyber Medical College, Peshawar, Pakistan.

BMJ Open
|April 7, 2025
PubMed

Insights

Childhood immunisation rates are suboptimal, with only 43.3% of children fully vaccinated. Targeted interventions are crucial for improving vaccination coverage, especially in rural and less educated populations.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood immunisation is critical for preventing infectious diseases.
  • Suboptimal immunisation rates pose a significant public health challenge.
  • Understanding determinants of immunisation is key to improving coverage.

Purpose of the Study:

  • To determine the immunisation status of children under 2 years.
  • To identify factors associated with non-immunisation.
  • To explore the relationship between immunisation status and sociodemographic variables.

Main Methods:

  • Cross-sectional, questionnaire-based study at Khyber Teaching Hospital, Peshawar.
  • Sample size of 363 children under 2 years, determined by WHO formula.
  • Immunisation data verified via vaccination cards; sociodemographic factors collected.

Main Results:

  • Only 43.3% of children were fully immunised.
  • 32.5% were partially immunised, and 24.2% were unimmunised.
  • Sociodemographic factors like maternal education and residence were assessed.

Conclusions:

  • Childhood immunisation status in the study area is unsatisfactory.
  • Universal immunisation coverage requires sustained and targeted efforts.
  • Interventions should focus on rural and less educated communities.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...